1.M C Foster, D E Weiner, A G Bostom, et al. Filtration markers, cardiovascular disease, mortality, and kidney outcomes in stable kidney transplant recipients: the FAVORIT trial. Am J Transplant. 2017;17(9):2390-2399.
2.Levey AS, Coresh J, Tighiouart H, et al. Measured and estimated glomerular filtration rate: current status and future directions. Nat Rev Nephrol.2020;16(1):51-64.
3.Ying T, Gill J, Webster A, et al. Canadian-australasian randomised trial of screening kidney transplant candidates for coronary artery disease—a trial protocol for the CARSK study. Am Heart J. 2019;214:175-183.
4.Sarnak MJ, Amann K, Bangalore S, et al. Chronic kidney disease and coronary artery disease: JACC state-of-the-art review. J Am Coll Cardiol. 2019;74(14):1823-1838.
5.Chen J, Budoff MJ, Reilly MP, et al. Coronary artery calcification and risk of cardiovascular disease and death among patients with chronic kidney disease. JAMA Cardiol. 2017;2(6):635-643.
6.Al‐Naher A, Wright D, Devonald MAJ, et al. Renal function monitoring in heart failure–what is the optimal frequency? A narrative review. Br J Clin Pharmacol. 2018;84(1):5-17.
7.Jenkins R, Mandarano L, Gugathas S, et al. Impaired renal function affects clinical outcomes and management of patients with heart failure. ESC Heart Fail. 2017;4(4):576-584.
8.Shlipak MG, Heidenreich PA, Noguchi H, et al. Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med. 2002;137(7):555-62.
9.Thakar CV, Christianson A, Freyberg R, et al. Incidence and outcomes of acute kidney injury in intensive care units: a Veterans Administration study. Crit Care Med. 2009;37(9):2552-8.
10.Mullens W, Damman K, Testani JM, et al. Evaluation of kidney function throughout the heart failure trajectory–a position statement from the heart failure association of the european society of cardiology. Eur J Heart Fail. 2020;22(4):584-603.
11.Karki P, Agrawaal K, Lamsal M, et al. Predicting outcomes in acute coronary syndrome using biochemical markers. Indian Heart J. 2015;67(6):529-37.
12.Lin T-H, Hsin H-T, Wang C-L, et al. Impact of impaired glomerular filtration rate and revascularization strategy on one-year cardiovascular events in acute coronary syndrome: data from Taiwan acute coronary syndrome full spectrum registry. BMC Nephrol. 2014;15(1):1-9.
13.El-Menyar A, Zubaid M, Sulaiman K, et al. In-hospital major clinical outcomes in patients with chronic renal insufficiency presenting with acute coronary syndrome: data from a registry of 8176 patients. Mayo Clin Proc.2010 ;85(4):332-40.
14.Al Suwaidi J, Reddan D, Williams K, et al. Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. Circulation. 2002;106(8):974-80.
15.Nabais S, Rocha S, Costa J, et al. Prognostic impact of moderate renal dysfunction in acute coronary syndromes. Rev Port Cardiol.2008 ;27(3):303-12.
16.Sooklim K, Srimahachota S, Boonyaratavej S, et al. Renal dysfunction as an independent predictor of total mortality after acute coronary syndrome: the Thai ACS Registry. J Med Assoc Thai. 2007;90(1):32-40.
17.Anavekar NS, McMurray JJ, Velazquez EJ, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med. 2004;351(13):1285-95.